RxDoctor Payments DataLook up a doctor →

Stuart Isaacson, MD

Neurology · Boca Raton, FLNPI 1023059169

Payments from drug & device makers

$10,530,992in general payments, 2019–2025

Across 4,707 payments — averaging $2237.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.1M
  • Sanofi$1M
  • H. Lundbeck A S$980K
  • MDD US Operations, LLC$879K
  • Amneal Pharmaceuticals LLC$745K
  • Teva Pharmaceuticals USA, Inc.$641K
  • plus $5.2M from 49 others
$313,666in research payments, 2019–2025

Across 38 payments — averaging $8254.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amneal Pharmaceuticals LLC$231K
  • Acadia Pharmaceuticals Inc$67K
  • MDD US Operations, LLC$12K
  • Eli Lilly$2K
  • Sanofi$1K
  • Neurocrine Biosciences, Inc.$560
  • plus $180 from 2 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)518$1,066,736
Sanofi89$1,012,448
H. Lundbeck A S198$979,598
MDD US Operations, LLC889$878,877
Amneal Pharmaceuticals LLC283$745,187
Teva Pharmaceuticals USA, Inc.469$640,792
Acadia Pharmaceuticals Inc464$604,763
Neurocrine Biosciences, Inc.428$513,293
Biogen11$454,168
Sunovion Pharmaceuticals Inc.165$412,096
UCB SA28$405,763
Genentech, Inc.28$388,692
Sage Therapeutics, LLC43$363,117
Kyowa Kirin, Inc.216$330,946
Roche TCRC, Inc.74$319,582
Acorda Therapeutics, Inc196$260,259
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)93$256,408
Eli Lilly11$151,525
Adamas Pharmaceuticals, Inc.92$116,278
Biohaven Pharmaceuticals, Inc.55$91,140
Amylyx Pharmaceuticals, Inc.25$76,142
Jazz Pharmaceuticals Inc.59$53,168
Merz Pharmaceuticals, LLC49$48,841
Regeneron54$47,054
Integrative Research Laboratories Sweden AB11$42,806
Novartis3$40,352
Ipsen Innovation10$37,409
Biohaven Pharmaceutical Holding Company Ltd.22$36,717
Kyowa Kirin Co., Ltd9$35,906
Lundbeck LLC46$29,615
Sumitomo Pharma America, Inc.3$28,250
GE HealthCare2$21,093
Cala Health, Inc.8$11,284
Genentech USA, Inc.6$7,208
Kyowa Kirin Services Ltd1$6,000
Tanabe Pharma America, Inc.5$5,210
Supernus Pharmaceuticals, Inc.3$3,227
F. Hoffmann-la Roche AG1$2,900
Global Kinetics USA Corporation1$1,500
Sanofi US Services Inc.1$850
UCB, Inc.2$776
Bayer5$637
Avion Pharmaceuticals4$596
Vertex1$442
Ipsen Biopharmaceuticals, Inc1$370
Merz North America, Inc.7$282
Abbott5$278
Revance Therapeutics, Inc.2$215
Lilly USA, LLC3$45
Almatica Pharma LLC2$39
Arbor Pharmaceuticals, Inc.2$38
Azurity Pharmaceuticals, Inc.1$24
Avanir Pharmaceuticals, Inc.1$20
Vertical Pharmaceuticals, LLC1$18
Insightec,inc1$15

How this compares

$10,530,992 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$237,524
Medicare patients
361
Services billed
4,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Boca Raton

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →